Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02705105 · ClinicalTrials.gov registry record · Phase 1

Study of Mogamulizumab + Nivolumab in Subjects w/Locally Advanced or Metastatic Solid Tumors

A Phase 1 study of Cancer and Solid Tumor, sponsored by Kyowa Kirin.

Completed
Registry status
Phase 1
Development phase
114
Enrollment target
15
Study locations

NCT02705105 is a Phase 1 study of Cancer and Solid Tumor that has completed, run by Kyowa Kirin. The registered enrollment target is 114 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (97% lower). The trial reports 15 study locations across 14 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02705105, a Phase 1 study of Cancer and Solid Tumor, has completed, sponsored by Kyowa Kirin.

COMPLETED
Registry status
Phase 1
Development phase
114 participants
Enrollment target
15
Study locations

Study Summary

The purpose of this study is to characterize the safety and tolerability and determine the maximum tolerated dose (MTD) or the recommended fixed dose of the combinations of mogamulizumab and nivolumab in subjects with locally advanced or metastatic solid tumors.

Conditions Studied

Cancer Solid Tumor Hepatocellular Carcinoma Carcinoma HCC

Interventions

  • BIOLOGICAL Mogamulizumab + Nivolumab

Study Locations (15)

California

  • - Greenbrae
  • - Los Angeles

Arizona

  • - Gilbert

Florida

  • - Jacksonville

Georgia

  • - Augusta

Illinois

  • - Chicago

Maryland

  • - Baltimore

Michigan

  • - Kalamazoo

New Jersey

  • - Piscataway

Trial Details

FieldValue
Enrollment Target 114 participants
Start Date 2016-02
Est. Completion 2018-10-10
Phase Phase 1

Sponsor

Kyowa Kirin

34 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02705105

The ClinicalTrials.gov registry entry for NCT02705105 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 114 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (97% lower). The listed sponsor is Kyowa Kirin, which has 34 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which Mogamulizumab + Nivolumab is the first listed.

NCT02705105 reports 15 study locations spanning 14 distinct geographic areas - top geographies include California, Arizona, Florida.

Frequently Asked Questions

What is clinical trial NCT02705105 about?

NCT02705105 is a clinical study titled "Study of Mogamulizumab + Nivolumab in Subjects w/Locally Advanced or Metastatic Solid Tumors". The purpose of this study is to characterize the safety and tolerability and determine the maximum tolerated dose (MTD) or the recommended fixed dose of the combinations of mogamulizumab and nivolumab in subjects with locally advanced or metastatic solid tumors.

What is the current status of trial NCT02705105?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 114 participants. The study started on 2016-02. Estimated completion is 2018-10-10.

What conditions does trial NCT02705105 study?

This clinical trial studies the following conditions: Cancer, Solid Tumor, Hepatocellular Carcinoma, Carcinoma, HCC.

What interventions are being tested in trial NCT02705105?

The interventions under investigation include: Mogamulizumab + Nivolumab (BIOLOGICAL).

Who is sponsoring clinical trial NCT02705105?

This trial is sponsored by Kyowa Kirin, which has 34 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02705105 being conducted?

This trial has 15 study locations across Arizona, California, Florida, Georgia, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Cancer

All registered trials for this condition

Solid Tumor

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.